Thomas Douthitt, Caeli Vascular - Catheter-Based Multi-Modal Technology Platform | LSI USA '24

Caeli Vascular has developed a proprietary catheter-based multi-modal technology platform for the treatment of venous obstructive disease along the entire continuum of disease from early acute through chronic stages.

LSI Europe ‘24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 16-20, 2024 The Ritz-Carlton - Sintra, Portugal Register arrow